Regenxbio Inc (NAS:RGNX)
$ 8.92 0.16 (1.83%) Market Cap: 440.86 Mil Enterprise Value: 228.13 Mil PE Ratio: 0 PB Ratio: 1.26 GF Score: 65/100

Regenxbio Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) Transcript

Apr 25, 2023 / 01:30PM GMT
Release Date Price: $18.92 (-1.25%)
Daniil Gataulin
Chardan - Analyst

Good morning, and thank you for attending Chardan's seventh Annual Genetic Medicines Manufacturing Summit. Now, my name is Daniil Gataulin. I'm one of the senior research analyst covering biotech here at Chardan.

It is my pleasure to introduce our next guest, Craig Malzahn, SVP, Technical Operations, at REGENXBIO. Craig, welcome.

Craig Malzahn
REGENXBIO Inc. - SVP, Technical Operations

Thank you. Good morning.

Daniil Gataulin
Chardan - Analyst

Good morning. The format for this session is a roughly 25 minute fireside chats. (Operator Instructions) With that, let's get started. Over to you, Craig.

Craig Malzahn
REGENXBIO Inc. - SVP, Technical Operations

All right. I just want to share real quickly here a little bit of a video montage of our new manufacturing facility. Yeah, so this is the REGENXBIO manufacturing facility that we opened for operation last summer. The REGENXBIO Manufacturing Innovation Center is a GMP gene

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot